INTERNATIONAL PATENT: AVIDITY BIOSCIENCES, INC., FRED HUTCHINSON CANCER CENTER FILES APPLICATION FOR "NOVEL BIOMARKER FOR DETERMINING DISEASE ACTIVITY OR PROGNOSIS OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY"

GENEVA, May 13 -- AVIDITY BIOSCIENCES, INC. (3020 Callan RoadSan Diego, California 92121), FRED HUTCHINSON CANCER CENTER (1100 Fairview Avenue NorthSeattle, Washington 98109) filed a patent application (PCT/US2025/053163) for "NOVEL BIOMARKER FOR DETERMINING DISEASE ACTIVITY OR PROGNOSIS OF FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY" on Oct 29, 2025. With publication no. WO/2026/096668, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CANTON, David Anthony (3020 Callan RoadSan Diego, California 92121), LIU, Xueqing (3020 Calla...